We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Arcis Biotechnology Launches IVD for the Preparation of DNA from Blood
Product News

Arcis Biotechnology Launches IVD for the Preparation of DNA from Blood

Arcis Biotechnology Launches IVD for the Preparation of DNA from Blood
Product News

Arcis Biotechnology Launches IVD for the Preparation of DNA from Blood


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Arcis Biotechnology Launches IVD for the Preparation of DNA from Blood"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Arcis Biotechnology has announced the launch of its Arcis DNA Blood Kit (IVD), for preparation of DNA from blood using a novel three minute two step system, designed for in vitro diagnostic use. The new kit is sold in a ready-to-use format, and enables users to stabilise and extract nucleic acid from fresh or frozen whole blood samples in just three minutes, without the need for prior sample preparation steps.

Arcis DNA Blood Kit is also suitable for specimens that have been stored in EDTA and heparin-containing solutions. The kit is non-hazardous, and ships and stores at room temperature for ease of handling. Designed with point-of-care in vitro diagnostics in mind, DNA extracted using the kit is also suitable for use in PCR or other applications.

Christopher Jones, Commercial Director, Arcis Biotechnology, commented: “The new Arcis DNA Blood Kit is the first product we have developed specifically for use up front of IVD and point-of-care technologies. Where access to instrumentation required for traditional extraction methods is not practical, this kit’s practicality and ability to be shipped and stored at ambient temperatures has big upsides for users in emerging markets.”

In February Arcis Biotechnology announced it had raised £2.5 million in an oversubscribed fundraising round. Now valued at circa £15 million, the company said the investment will be used to continue to commercialise its ground-breaking R&D-led portfolio of products.

Advertisement